 | This article has multiple issues. Please helpimprove it or discuss these issues on thetalk page.(Learn how and when to remove these messages) (Learn how and when to remove this message)
|
 | |
Native name | ロート製薬株式会社 |
|---|---|
Romanized name | Rōto Seiyaku kabushiki gaisha |
| Company type | Public |
| TYO:4527 | |
| Industry | |
| Founded | Higashinari-ku, Osaka, Japan (September 15, 1949 (1949-09-15), to reorganize "Shintendo, Yasutami Yamada pharmaceutical Company") |
| Founder | Yasutami Yamada |
| Headquarters | Ikuno-ku, Osaka, Japan |
Key people | |
| Revenue |
|
| |
| |
| Total assets |
|
| Total equity |
|
Number of employees | 7,259 (as of March 31, 2024) |
| Subsidiaries | Mentholatum Rohto Advanced Research Hong Kong Ltd |
| Website | www |
| Footnotes / references | |
Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社,Rōto Seiyaku Kabushiki-gaisha) is a Japanese multinational corporation specializing infast-moving consumer goods andpharmaceuticals, headquartered inIkuno-ku,Osaka, Japan.[1] The company primary focuses on skin and eye care products. They also produce cosmetics, supplements, andover-the-counter medications.[1]
In 1975, Rohto gained trademark rights toMentholatum fromThe Mentholatum Company Inc., allowing the sale of Mentholatum-branded products.[2] Rohto acquired The Mentholatum Company Inc. in June 1988.[2][3]
Rohto has two production plants in Japan and six across the US, UK, China, Vietnam, Hong Kong, and Indonesia. Rohto entered the Vietnamese market in 1997 expanding sales to the Asia Pacific region. In mid-2010, Rohto entered the Indian andBangladeshi markets.
In 2024, Rohto Pharmaceutical entered into a partnership with the Austrian Sigmapharm Group. This partnership aimed at expanding the production and sale ofophthalmic drugs and medical products across Europe, with Rohto Pharmaceutical investing nearly €30 million in research, development, production, and sales.[4]
Yasutami Yamada (山田 安民) founded "Japanese:信天堂山田安民薬房,lit. 'Shintendo Yamada Yasutami Pharmacy'" in Osaka, on February 22, 1899.[2] ROHTO Pharmaceutical Co. is the largest company in Japan's OTC drugs market[citation needed], commanding a 40% share in the eye-drop sector.[3] The name "Rohto" was inspired byAugust von Rothmund,[note 1] a Germanophthalmologist who was a professor for Toyotaro Inoue (井上 豊太郎,Inoue Toyotarō), a Japanese ophthalmologist.
International Directory of Company Histories
| International | |
|---|---|
| National | |
